Replay available

Inspire Medical Systems, Inc. (INSP) Q2 2026 Earnings Call

Inspire Medical Systems, Inc. (NYSE: INSP) Q2 2026 earnings conference call, held 2026-08-03. Replay captured from the company's public earnings webcast.

Mon, August 3, 2026 at 5:00 PMendedReplay
Inspire Medical Systems, Inc. (INSP) Q2 2026 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Ezgi Yagci

Vice President, Investor Relations

Tim Herbert

Chairman and Chief Executive Officer

Matt Osberg

Chief Financial Officer

John Block

Analyst, Stifel

Adam Nader

Analyst, Piper Sandler

Robbie Marcus

Analyst, J.P. Morgan

Anthony Petroni

Analyst, Missoula Americas

Larry Beagleson

Analyst, Wells Fargo

Richard Newiter

Analyst, Truist Securities

Brett Fishbin

Analyst, KeyBank Capital Markets

Daniel Markowitz

Analyst, Evercore ISI

Keith Hinton

Analyst, Freedom Capital Markets

Replay transcript excerpt

Good afternoon. My name is Dilem, and I'll be your conference operator today. At this time, I'd like to welcome everyone to the Inspire Medical Systems second quarter 2026 conference call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there'll be a question and answer session. I'll now hand the call over to your first speaker, Ezgi Yagci, the Vice President of Investor Relations at Inspire. You may begin the conference. Thank you, Dilem, and thank you all for participating in today's call. Joining me are Tim Herbert, Chairman and Chief Executive Officer, and Matt Osberg, Chief Financial Officer. Earlier today, we released financial results for the three months ended June 30th, 2026. A copy of the press release is available on our website. On this call, management will make forward-looking statements within the meaning of the federal securities laws. all forward-looking statements including, without limitation, those relating to our operations, financial results and financial condition, investments in our business, full-year 2026 financial and operational outlook, and changes in market access and different aspects of coding or reimbursement are based upon our current estimates and various assumptions. Forward-looking statements involve material risks and uncertainties that could cause actual results or events to materially differ. Accordingly, you should not place undue reliance on these statements. For a discussion of these risks and uncertainties, please see our filings with the Securities and Exchange Commission, including our periodic reports on Form 10-K and 10-Q, as well as the Form 10-Q which we filed this afternoon with the SEC for the quarter ended June 30, 2026. INSPIRE disclaims any intention or obligation,...

More from Inspire Medical Systems, Inc.